Care Team Structure & Evidence

Federal regulation (42 CFR §418.56) requires Medicare-certified hospices to provide care through an interdisciplinary group (IDG) that includes at minimum a physician, nurse, social worker, and pastoral or counseling services representative — with the patient and family treated as part of the team.

The Service Intensity Add-on (SIA; 42 CFR §418.302) provides additional Medicare payment for registered nurse and medical social worker visits in the last 7 days of life for patients on the Routine Home Care (RHC) level of care — creating a financial incentive to increase skilled bedside presence at end of life.

CMS tracks two claims-based quality measures for hospice quality reporting: the Hospice Visits in the Last Days of Life (HVLDL) measure — whether patients received a skilled visit in the last 3 days — and the Hospice Care Index (HCI), a composite of ten care quality indicators. Both are publicly reported and inform value-based payment discussions.

The Home Health Value-Based Purchasing (HHVBP) Model expanded nationwide in January 2023. Home health agencies receive payment adjustments of up to ±5% based on their Total Performance Score (TPS), incentivizing quality improvement across clinical and functional outcomes for Medicare home health patients.

Home health Conditions of Participation (42 CFR §484.55) require a comprehensive patient assessment at the start of each care episode, including functional status, medication management, and care coordination needs — establishing the regulatory baseline for quality home-based palliative and post-acute care.

The SUPPORT trial (1995) — a large, well-powered RCT of a communication and advance care planning intervention in seriously ill hospitalized patients — found no statistically significant improvement in pain control, time to do-not-resuscitate orders, patient-physician communication, or resource use. This null finding remains foundational to understanding the limits of information-only ACP interventions.

A 2016 systematic review and meta-analysis of 43 RCTs found that palliative care was associated with significant improvements in patient quality of life and symptom burden compared to usual care. No significant association with survival was found (HR 0.90; 95% CI, 0.69–1.17). The evidence base supports early integration of specialty palliative care alongside disease-directed treatment.

A home-based palliative care program embedded in a Medicare Shared Savings Program (MSSP) ACO reduced total costs and hospitalizations — demonstrating that proactive palliative care team deployment creates measurable quality and financial outcomes within value-based models.

Workforce projections published in 2018 indicated a growing mismatch between the supply of hospice and palliative medicine specialist physicians and projected demand. The gap is expected to widen as the aging population increases need for specialist palliative care services.

In a single-center study of 2,031 patients with cancer who died 2018–2022, more comprehensive goals-of-care documentation was associated with less aggressive end-of-life care: 73.2% received aggressive care when none of eight GOC components were documented, versus 50.3% when seven were.

The most documented goals-of-care component was family involvement (75.0%); the least was fears (21.1%); only 5.4% of patients had all eight components documented.

In the CAPC Serious Illness Scorecard Michigan State Report, Michigan hospitals reporting palliative care by bed size: 67.4% (<50), 68.4% (50–149), 86.7% (150–299), 92.6% (300+); an estimated 92.1% of Michigan inpatients may have access to hospital-based palliative care.

Michigan has 286 certified palliative-care prescribers (2.9 per 100,000), no standalone Medicaid palliative benefit, and no legislatively established palliative care advisory council; it ranks 17/51 (C-TAC ACT Index) and 31/51 (AARP LTSS Scorecard).

A 2025 scoping review found 44 measures for goal-concordant care. No agreed criterion standard; measures vary in construct and validation.

An EHR-notes method for identifying goal-concordant care achieved strong inter-rater agreement (κ=0.92).

CANHELP is validated as a measure of patient and family satisfaction with end-of-life care, not as a measure of goal concordance.

In the ACP PEACE stepped-wedge cluster RCT (NCT03609177), a communication intervention increased advance-care-planning documentation by 6.8 percentage points (25.3% vs 20.8%; P<.001, primary outcome) but did not significantly change palliative care or hospice enrollment.

In a single-institution retrospective study (N=60 patients, Dana-Farber), GPT-4o identified advance-care-planning documentation in EHRs with sensitivity 0.85–1.0 and specificity 0.80–0.91 across ACP domains; hallucination index was low (<0.5). Limitations include small sample size and single-site design.

In a structured ethical stress test of 14 large language models on hospice and medical dilemmas, 7 of 14 endorsed ethically impermissible actions; 6.3% of outputs endorsed involuntary hospice transfer. Authors note these findings derive from a forced-choice stress test and do not generalize to routine clinical use.

A 2026 scoping review of 42 studies on AI in advance care planning found that use of generative AI is 'limited,' rule-based NLP dominates, and no randomized controlled trials of AI-delivered ACP conversations with patients have been published.

A 2026 scoping review of 15 studies on AI in palliative care characterized the evidence as 'geographically skewed, methodologically immature, and ethically underdeveloped'; only 2 of 15 studies measured quality of life directly.

Clinicians from MSK, MGH, Mayo Clinic, and Johns Hopkins published interdisciplinary practical guidance on AI for palliative care clinicians in 2026; no formal position statement from AAHPM, NHPCO, ASCO, or NCI on AI in palliative care has been identified in 2024–2026.